Tyler Zeronda - May 31, 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
CFO
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol
VYNE
Transactions as of
May 31, 2022
Transactions value $
$4,332
Form type
4
Date filed
6/2/2022, 04:36 PM
Previous filing
Apr 4, 2022
Next filing
Jul 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Award $4.33K +12.5K +7.74% $0.35 174K May 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period).